Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Educational Status × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 17 Lung Neoplasms 15 Colorectal Neoplasms 12 Prostatic Neoplasms 11 Lymphoma 5 Hematopoietic and Lymphatic System Neoplasm 5 Hematologic Neoplasms 5 Melanoma 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Obesity-Related Malignant Neoplasm 3 Neoplasms 3 Neoplasm Metastasis 3 Malignant Solid Neoplasm 3 Carcinoma, Non-Small-Cell Lung 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Malignant Solid Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Papillomavirus Infections 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Hematopoietic and Lymphoid System Neoplasm 2 Healthy Subject 2 Genital Neoplasms, Female 2 Gastrointestinal Neoplasms 2 Fatigue 2 Crohn Disease 2

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡